We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00003754
First Posted: April 9, 2004
Last Update Posted: June 26, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Memorial Sloan Kettering Cancer Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2001
  Primary Completion Date: July 2001 (Final data collection date for primary outcome measure)